Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 3 Glioblastoma 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Triple Negative Breast Neoplasms 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Persistent Infection 1 Neoplasm Metastasis 1 Melanoma 1 Glioma 1 Diffuse Intrinsic Pontine Glioma 1 Condylomata Acuminata 1 Colonic Neoplasms 1 Anus Neoplasms 1

Interventions

Carboplatin 47 Etoposide 46 durvalumab 28 atezolizumab 28 Cisplatin 21 Topotecan 19 pembrolizumab 15 PM 01183 15 Nivolumab 12 Specimen Handling 11 anlotinib 9 Radiotherapy 9 Paclitaxel 9 Drug Therapy 9 Temozolomide 8 Magnetic Resonance Spectroscopy 8 AMG 757 8 Radiosurgery 7 Platinum 7 Irinotecan 7 toripalimab 6 olaparib 6 Biopsy 6 Ipilimumab 5 Injections 5 Docetaxel 5 Bevacizumab 5 trilaciclib 4 tremelimumab 4 tislelizumab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Small Cell Lung Carcinoma × Vaccines × 1 year × Clear all

NCT04487756 2026-06-02

VENEZO-LUNG

Instituto Oncológico Dr Rosell

Phase 1/2 Completed

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡